Search research articles
Contact Us
Filters
Showing results (31-40 of 65) with videos related to
Page
of 7
Sort By:
Scientific Reports
|
April 28, 2025
Author Correction: Circulating microRNA-155-3p levels predicts response to first line immunotherapy in patients with metastatic renal cell carcinoma
Maryam Soleimani, Marisa Thi, Sajjad Janfaza, et al.
Scientific Reports
|
April 13, 2024
Circulating microRNA-155-3p levels predicts response to first line immunotherapy in patients with metastatic renal cell carcinoma
Maryam Soleimani, Marisa Thi, Sajjad Janfaza, et al.
Plos One
|
May 9, 2025
Matching plasma and tissue miRNA expression analysis to detect viable ovarian germ cell tumors
Arkhjamil Angeles, Nastaran Khazamipour, Gurdial Dhillon, et al.
Proteomics
|
January 3, 2013
Increased anaerobic metabolism is a distinctive signature in a colorectal cancer cellular model of resistance to antiepidermal growth factor receptor antibody
Francesca Monteleone, Roberta Rosa, Monica Vitale, et al.
EMBO Molecular Medicine
|
May 21, 2016
Clusterin knockdown sensitizes prostate cancer cells to taxane by modulating mitosis
Nader Al Nakouzi, Chris Kedong Wang, Eliana Beraldi, et al.
Frontiers in Oncology
|
September 30, 2022
Comprehensive immune profiling of patients with advanced urothelial or renal cell carcinoma receiving immune checkpoint blockade
Jean-Michel Lavoie, Priya Baichoo, Elizabeth Chavez, et al.
Anti-Cancer Drugs
|
May 23, 2013
Tumor-to-tumor metastasis: breast cancer metastatic to thymic epithelial tumor
Roberto Moretto, Chiara A Cella, Lucia Raimondo, et al.
The Prostate
|
November 29, 2022
Exploring new frontiers in prostate cancer research: Report from the 2022 Coffey-Holden prostate cancer academy meeting
Andrea K Miyahira, Jessica E Hawley, Remi Adelaiye-Ogala, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 15, 2021
Effectiveness of first-line abiraterone versus enzalutamide among patients ≥80 years of age with metastatic castration-resistant prostate cancer: A retrospective propensity score-weighted comparative cohort study
Maryam Soleimani, Kevin Zou, Katherine Sunderland, et al.
The Oncologist
|
September 27, 2022
TP53 Alterations Are Associated With Poor Survival in Patients With Primary Mediastinal Nonseminoma Germ Cell Tumors
Jack V W Bacon, Patrizia Giannatempo, Giovanna Cataldo, et al.
Page
of 7
Search research articles
Search
Showing results (31-40 of 65) with videos related to
Sort By:
Page
of 7
Scientific Reports
|
April 28, 2025
Author Correction: Circulating microRNA-155-3p levels predicts response to first line immunotherapy in patients with metastatic renal cell carcinoma
Maryam Soleimani, Marisa Thi, Sajjad Janfaza, et al.
Scientific Reports
|
April 13, 2024
Circulating microRNA-155-3p levels predicts response to first line immunotherapy in patients with metastatic renal cell carcinoma
Maryam Soleimani, Marisa Thi, Sajjad Janfaza, et al.
Plos One
|
May 9, 2025
Matching plasma and tissue miRNA expression analysis to detect viable ovarian germ cell tumors
Arkhjamil Angeles, Nastaran Khazamipour, Gurdial Dhillon, et al.
Proteomics
|
January 3, 2013
Increased anaerobic metabolism is a distinctive signature in a colorectal cancer cellular model of resistance to antiepidermal growth factor receptor antibody
Francesca Monteleone, Roberta Rosa, Monica Vitale, et al.
EMBO Molecular Medicine
|
May 21, 2016
Clusterin knockdown sensitizes prostate cancer cells to taxane by modulating mitosis
Nader Al Nakouzi, Chris Kedong Wang, Eliana Beraldi, et al.
Frontiers in Oncology
|
September 30, 2022
Comprehensive immune profiling of patients with advanced urothelial or renal cell carcinoma receiving immune checkpoint blockade
Jean-Michel Lavoie, Priya Baichoo, Elizabeth Chavez, et al.
Anti-Cancer Drugs
|
May 23, 2013
Tumor-to-tumor metastasis: breast cancer metastatic to thymic epithelial tumor
Roberto Moretto, Chiara A Cella, Lucia Raimondo, et al.
The Prostate
|
November 29, 2022
Exploring new frontiers in prostate cancer research: Report from the 2022 Coffey-Holden prostate cancer academy meeting
Andrea K Miyahira, Jessica E Hawley, Remi Adelaiye-Ogala, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 15, 2021
Effectiveness of first-line abiraterone versus enzalutamide among patients ≥80 years of age with metastatic castration-resistant prostate cancer: A retrospective propensity score-weighted comparative cohort study
Maryam Soleimani, Kevin Zou, Katherine Sunderland, et al.
The Oncologist
|
September 27, 2022
TP53 Alterations Are Associated With Poor Survival in Patients With Primary Mediastinal Nonseminoma Germ Cell Tumors
Jack V W Bacon, Patrizia Giannatempo, Giovanna Cataldo, et al.
Page
of 7